Home -> Law Blog Directory -> Constitutional Law Blogs -> ACS Blog
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Constitutional Law
: ACS BlogACS Week in Review: Aug 16 - Aug 22
A discussion of whether the legal academy is sufficiently preparing students to meet their duty to serve the public in times of crisis by Douglas Colbert, professor of law, University of Maryland School of Law, and a Board member of the Society of American Law Teachers (SALT).
An argument in favor of a policy facilitating post-conviction DNA testing for defendants claiming innocence by John F. Terzano, President of The Justice Project.
A critical look at the United State’s policy of exporting electrical and electronic waste by Daniella Gayapersad-Chan, a member of the Board of Directors for the Disaster Accountability Project and President of Howard Public Interest Law Society.
An overview of Osama bin Laden’s alleged media director Hamza Ahmed’s boycott of his military commission trial and an update on the proceedings of his military commission trial of Mohammed Jawad , by Nicole Barrett, a Human Rights First volunteer consultant and former trial attorney at the International Criminal Tribunal for the former Yugoslavia.
A summary of a federal appeals court ruling on a Tennessee public school’s ban on students wearing clothing with the Confederate flag.
A recap of California Supreme Court’s findings in case over health care professionals’ refusals to provide medical services to lesbians and gay men.
Full post as published by ACS Blog on August 22, 2008 (boomark / email).
FDA Issues Update on Safety Review Orlistat
Orlistat FDA Issues Update on Safety Review
Aurora Loan Faces Class Action over Mortgage Review Services
Aurora Loan Faces Class Action over Mortgage Review Services
FDA Review of Prostate Cancer Treatment Prompts Warning of Risk for Diabetes
Prostate Cancer Treatment FDA Review Prompts Warning of Risk for Diabetes
Xigris
Study Prompts FDA Safety Review
Lipitor
Review of Studies Show No Significant Benefit in Women
Wrinkle-Fillers
FDA to Review Labeling due to Adverse Event Reports









